Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209358) titled 'EDX110 Randomized Control Trial for Treatment of DFUs' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: ConvaTec Inc.
Condition:
Wound Heal
Diabetic Foot Ulcer
Intervention:
Device: EDX110
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2025
Target Sample Size: 298
To know more, visit https://clinicaltrials.gov/study/NCT07209358
Published by HT Digital Content Services with permission from Health Daily Digest....